Can Johnson & Johnson (JNJ) Challenge Intuitive Surgical (ISRG) After Ottava’s FDA Approval?
Johnson & Johnson (NYSE:JNJ) has officially entered the U.S. soft-tissue robotic surgery market after receiving FDA De Novo…
Can ISRG’s Digital Roadmap Unlock the Next Phase of Robotic Surgery?
Intuitive Surgical’s ISRG next growth frontier may not be a new robotic platform but the digital ecosystem being…
Intuitive Surgical’s Moat Is Getting Stronger — Is This the Closest Thing to a ‘Forever’ Stock?
Intuitive Surgical (NASDAQ: ISRG) hasn’t been a great stock to own this year. The company’s shares have declined…
Is This Robotic Surgery Titan the Secret to 100% Gains by 2030?
Intuitive Surgical is a leading provider of surgical robotics devices. Its da Vinci robot was one of the…
3 Things You Need to Know If You Buy Intuitive Surgical Today
Intuitive Surgical is at the cutting edge of surgery, with a still-growing base of surgical robots in the…